Best IMD Podcasts (2024)

1
Driving transformation by creating disequilibrium, with Hamilton Mann 37:08

9d ago37:08

37:08

Hamilton Mann, a top executive at European defense group Thales tells Michael Wade why creating objectives that take people out of their comfort zones is vital to driving collaboration and transformation at scale. ***** Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.By IMD

1
Footprints of IMD: Metabolic Epilepsies... with Phillip Pearl 30:47

24d ago30:47

30:47

Professor Phillip Pearl joins Eva Morava to discuss the footprints of metabolic epilepsies and a very brief introduction to the intertwined nature of music and neurology. Read the referenced paper here: https://doi.org/10.1016/j.ymgme.2023.107690Find IMDs associated with epilepsies at: http://iembase.org/gamuts/store/docs/IMDs_presenting_with_epile…

1
Defence tech: From TNT to AI 27:09

2h ago27:09

27:09

Michael Wade is a Professor of Innovation and Strategy and Director of the IMD Global Center for Digital Business Transformation. He also holds the Cisco Chair in Digital Business Transformation. An expert in digital transformation, he has published 10 books and more than 100 case studies, as well as articles on topics such as digital business tran…

1
Arnaud Vaissié of International SOS 44:44

2d ago44:44

44:44

Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.By IMD

1
Fatty acid homeostasis 18:09

1h ago18:09

18:09

Professors Fréd Vaz and Ronald Wanders present an entertaining and informative overview of fatty acid homeostasis and explain why the catabolic and anabolic processes cannot be considered separately.Disorders of fatty acid homeostasisFrédéric M. Vaz, et al https://doi.org/10.1002/jimd.12734By Journal of Inherited Metabolic Disease

1
Metabolic mysteries: Progressive neurological symptoms after a change in diet 6:30

14d ago6:30

6:30

Dr Annet Bosch describes three cases where young adults developed worsening neurological symptoms after a change in diet. Initially confused with Guillan-Barré Syndrome, this treatable condition may be hard to diagnose but devastating to miss. Find full details here: https://doi.org/10.1002/jmd2.12427…

1
Heterozygous DHDDS variants 18:00

11d ago18:00

18:00

Dr Irena Muffels is joined by Professor Eva Morava to discuss insights into heterozygous DHDDS variants, an autosomal dominant IMD that appears to impact on multiple different metabolic pathways. Assessing age of onset and clinical symptoms over time in patients with heterozygous pathogenic DHDDS variantsI. J. J. Muffels, et alhttps://doi.org/10.10…

1
The 'Trust Factor' in building strong GP-LP relationships, with Harshul Sanghi 13:54

13d ago13:54

13:54

In this new episode of Capital Conversations, Harshul Sanghi outlines the critical factors that underpin successful GP-LP relationships in venture capital, and the value of trust. Harshul Sanghi is a Co-Founding Partner at WillowTree Investments. During his tenure as head of the $1.3 billion venture capital division at American Express that he foun…

1
Gene replacement therapies for inherited disorders of neurotransmission: Progress in SSADH 17:53

1M ago17:53

17:53

Dr Henry Lee joins the podcast to discuss the challenges of developing gene therapies for inherited disorders of neurotransmission and shares the progress that his group has made with SSADH deficiency. Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiencyHenry H. …

1
How Silicon Valley firms are putting the "AI" in retail 17:35

26d ago17:35

17:35

This year, Amazon celebrated 30 years in business. By creating a virtual space where (almost) everything was available at the click of a button, the Seattle-based tech firm changed the face of retail. Tempted away from brick-and-mortar stores by the convenience of online shopping, Amazon created a whole new kind of consumer. However, not all of its…

1
Shortcast: Galactokinase 1 is the source of elevated gal-1-phosphate in a galactosemia mouse model 4:18

1M ago4:18

4:18

Dr Tom Hartl discusses his group's work with a mouse model that knocks out both GALT and GALK and the insights that this provides into classic galactosemia.Galactokinase 1 is the source of elevated galactose-1-phosphate and cerebrosides are modestly reduced in a mouse model of classic galactosemiaLinley Mangini, et alhttps://doi.org/10.1002/jmd2.12…

1
Tech & sports: Could your next coach be a computer? 17:28

1M ago17:28

17:28

In an era of desk jobs, sedentary lifestyles are common. Combined with the rise of ultra-processed food, it's no wonder so many people find it hard to stay in shape, despite their best intentions. To help out, there's a plethora of tech to choose from. From apps that count calories to wearable health trackers, innumerable gadgets promise a slimmer,…

1
Dietary management for pyridoxine-dependent epilepsy 29:37

1M ago29:37

29:37

Marjorie Dixon and Annemiek van Wegberg join guest host Curtis Coughlin II to complete the treatment puzzle in pyridoxine dependent epilepsy and explain the role and practicalities of lysine restriction in PDE.Dietary management for pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency, a follow-on from the intern…

1
S8 Episode 5 - A Rosebank Opening Special ft Leonard Russell, Tom Russell, Malcolm Rennie, Scott Jackson, Stephen Arnott and Rosie Murray 1:24:41

1M ago1:24:41

1:24:41

It’s a Rosebank Special and we are live at the opening night event featuring Managing Director and owner of Ian Macleod Distillers, Leonard Russell, Head of International Business Development Tom Russell, Gordon Dundas, and Distillery Manager Malcolm Rennie with a host of local Distillery Ambassadors giving us their take on the rebirth of this icon…

1
The Interview: David Bach speaks to Jason Price of NXTHVN 30:08

1M ago30:08

30:08

Jason Price, Founder and Chairman of the Board at NXTHVN, tells David Bach about the national arts model he has inaugurated which empowers artists, curators, and the community through education and access to a vibrant ecosystem. ***** Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.…

1
Pt.2 Specialization in action: Inside a specialist VC's playbook for success 17:48

1M ago17:48

17:48

Part 2 of Capital Conversations, with Evgenia Plotnikova. As technology advances and industries transform, venture capitalists face a critical decision: should they cast a wide net, or home in on a niche? To guide investors through this choice, Evgenia Plotnikova, General Partner at Dawn Capital, has sat down with IMD's venture asset management tea…

1
Footprints of IMD: Metabolic Liver Disease... with David Cassiman 20:20

1M ago20:20

20:20

Nenad Blau hosts Professor David Cassiman as he explains when to consider a metabolic differential in pediatric and adult liver disease. Read the referenced paper here: https://doi.org/10.1016/j.ymgme.2019.04.002Find liver disorders associated with IMDS at: http://iembase.org/gamuts/store/docs/Liver_disorders_in_inherited_metabolic_disorders.pdf…

1
Shortcast: Normal transferrin glycosylation does not rule out severe ALG1 deficiency 4:46

2M ago4:46

4:46

In the latest shortcast, Inez Bosnyak describes a case of ALG1-CDG presenting without an abnormal isoelectric focusing pattern. Normal transferrin glycosylation does not rule out severe ALG1 deficiencyInez Bosnyak, et alhttps://doi.org/10.1002/jmd2.12415By Journal of Inherited Metabolic Disease

1
Ringing the changes: Vodafone ‘insider’ makes some tough calls as CEO 41:21

2M ago41:21

41:21

Margherita Della Valle tells IMD President Jean-François Manzoni how she is delivering radical change to reenergize Vodafone and paving the way for greater diversity in leadership. -- Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.By IMD

1
The Interview: Michael Wade speaks to Joseph Bradley 26:41

2M ago26:41

26:41

The boundary between the physical and digital worlds is dissolving, says Joseph Bradley, CEO of TONOMUS, a world-leading technology enterprise powering the world’s first ecosystem of cognitive technologies at NEOM in Saudi Arabia. Harnessing the power of data, while addressing the risks, will be key to an enhanced integrated future. ***** Read our …

1
Speech & neural oscillation in classic galactosemia 23:16

2M ago23:16

23:16

Dr Estela Rubio-Gozalbo and Dr Bernadette Jansma explain why brains oscillate, what that has to do with classical galactosemia and how a non-invasive intervention could help with language difficulties. Altered neural oscillations in classical galactosaemia during sentence productionSara Mazzini, et alhttps://doi.org/10.1002/jimd.12740Impact of thet…

1
Tech & sports: The rise of Esports 17:50

2M ago17:50

17:50

Mike and Amit discuss how games like football and tennis have paved the way for the $2bn industry of Esports. ********* Michael Wade is a Professor of Innovation and Strategy and Director of the IMD Global Center for Digital Business Transformation. He also holds the Cisco Chair in Digital Business Transformation. An expert in digital transformatio…

1
Specialization in action: Inside a specialist VC's playbook for success 16:38

2M ago16:38

16:38

As technology advances and industries transform, venture capitalists face a critical decision: should they cast a wide net, or home in on a niche? To guide investors through this choice, Evgenia Plotnikova, General Partner at Dawn Capital, has sat down with IMD's venture asset management team. As the youngest woman in Europe to be internally promot…

1
Shortcast: Late-onset refractory hemolytic anemia in siblings treated for MTRR deficiency 8:46

2M ago8:46

8:46

Alexandre Nguyen and Manuel Schiff share the story of two siblings with severe haemolytic anaemia developing in previously well controlled methionine synthase reductase deficiency.Late-onset refractory hemolytic anemia in siblings treated for methionine synthase reductase deficiency: A rare complication possibly prevented by hydroxocobalamin dose e…

1
The Interview: The G7 gangs up on China 13:24

2M ago13:24

13:24

Long treated as a photo opportunity for the leaders of Western democracies, the G7 has had a new lease of life ever since the Russian invasion of Ukraine. With so many G20 members at each other’s throats, the G7 has proved to be a useful vehicle to align against military aggression and the economic threats to Western business and technological prim…

1
Lessons from adult metabolic medicine 21:26

3M ago21:26

21:26

Dr Fanny Mochel returns to the podcast to answer the question, "What can pediatricians learn from adult inherited metabolic diseases?"What can pediatricians learn from adult inherited metabolic diseases?Fanny Mochelhttps://doi.org/10.1002/jimd.12729By Journal of Inherited Metabolic Disease

1
Tech in sports: How analytics has changed the pros 20:52

2M ago20:52

20:52

There's no doubt that statistics and data play an important role in professional sports. Whether in soccer, cricket, or American football, superfans have always been interested in goals scored, passes caught, or wickets taken. But the point at which the value of that data became apparent was the advent of "Moneyball" in the early 2000s, which revol…

1
Metabolic mysteries: A treatable condition masquerading as TORCH Infection 3:05

2M ago3:05

3:05

Dr Vykunta Raju K N, Professor of Paediatric Neurology discusses a child presenting with IUGR, microcephaly, cataracts, developmental delay, seizures, and cerebral atrophy.L-Serine Biosynthesis Defect: A Treatable Condition Masquerading as TORCH InfectionVykuntaraju K. Gowda et alhttps://link.springer.com/article/10.1007/s12098-024-05181-3…

1
Footprints of IMD: the IEMbase and Cerebral Palsy... with Gabriella Horvath 18:19

3M ago18:19

18:19

Eva Morava discusses the creation of the IEMbase with Nenad Blau before the pair welcome Gabriella Horvath to discuss metabolic mimics of cerebral palsy in the first episode of the footprints series. Read the referenced paper here: https://doi.org/10.1016/j.ymgme.2021.03.008Find all the metabolic mimics of CP at http://iembase.org/gamuts/store/docs…

1
Why Novo Nordisk’s CEO has learned to trust his gut feeling 49:08

3M ago49:08

49:08

Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.By IMD

1
Henkel’s Carsten Knobel: A CEO who sticks to his strategy 45:33

3M ago45:33

45:33

Henkel CEO Carsten Knobel tells IMD President Jean-François Manzoni why he has remained laser-focused on implementing its purposeful growth agenda and why the company decided to exit Russia.By IMD

1
Pregnancy in phenylketonuria 30:55

3M ago30:55

30:55

Dr Maja Risager Nielsen and Dr François Feillet discuss pregnancy in PKU and two different papers looking at the outcomes in pregnancies with and without BH4 treatment. The impact of phenylalanine levels during pregnancy on birth weight and later development in children born to women with phenylketonuriaMaja Risager Nielsen, et alhttps://doi.org/10…

1
ACWA Power’s Marco Arcelli: ‘I’m the Chief Facilitating Officer’ 47:43

3M ago47:43

47:43

A year into the job, Marco Arcelli, CEO of ACWA Power, tells IMD President Jean-François Manzoni how the Saudi company plans to triple assets to $250 billion in six years by expanding internationally.By IMD

1
Bertrand Mueller on the marriage of pension funds and VCs 18:53

3M ago18:53

18:53

With trillions in assets worldwide, pension funds play a dual role, acting as both asset and liability managers, influencing their exposure to venture capital. In this episode of Capital Conversations, Bertrand Mueller a founding partner at DAA Capital, uncovers the strategies and dynamics behind this often-overlooked relationship. We learn how pen…

1
S8Episode 4 - Spirit of Speyside 2024 Special ft Chairman George McNeil, Sandy McIntyre Tamdhu Manager and Jake Adcook IMD asst. blender 47:44

4M ago47:44

47:44

The 2 Gordon's welcome you to Dalbeallie station in the heart of the Tamdhu Distillery for a behind the scenes look at the SOSF 2024. Chairman of the Festival, George McNeil gives the podcast an exclusive interview from The Macallan who, celebrating their 200th anniversary were the official hosts of this years festival, themselves celebrating 25 ye…

1
Acute liver failure? Think metabolic 10:19

4M ago10:19

10:19

When might acute liver failure have a metabolic cause? Dr Robert Hegarty tries to answer this question and more following his recent review article on Genetic aetiologies of acute liver failure.Genetic aetiologies of acute liver failureRobert Hegarty, Richard J. Thompsonhttps://doi.org/10.1002/jimd.12733…

1
NVIDIA: The tech giant building the future of chips 16:15

3M ago16:15

16:15

Mike and Amit talk about the giant chipmaker NVIDIA, and how it's creating the technology of tomorrow. ********* Michael Wade is a Professor of Innovation and Strategy and Director of the IMD Global Center for Digital Business Transformation. He also holds the Cisco Chair in Digital Business Transformation. An expert in digital transformation, he h…

1
RWE’s Markus Krebber on building energy reserves to keep focused on the long term 47:43

4M ago47:43

47:43

By IMD

1
Aicardi-Goutières syndrome 32:44

4M ago32:44

32:44

Dr Mariko Bennett and Dr Laura Adang discuss the precarious balance between a protective and a destructive immune response, as is seen in inborn errors in nucleotide metabolism. Our discussion focuses on the most common of these disorders: Aicardi Goutières syndrome (AGS). Sadly, despite the many gains in understanding about AGS, there remain many …

1
Shortcast: Pediatric palliative care for IMD: 20-year survey of outpatients at a Brazilian hospital 4:30

4M ago4:30

4:30

Dr Gustavo Spolador discusses the paucity of data around palliative care in Inherited Metabolic Disease and some of his own observations in a Brazilian quaternary hospital.Pediatric palliative care for metabolic diseases: 20-year epidemiological survey of outpatients at a Brazilian quaternary hospitalGustavo Marquezani Spolador, et alhttps://doi.or…

1
Why does artificial intelligence need regulating? 19:50

4M ago19:50

19:50

In March 2024, the European Union approved the world’s first set of major regulatory rules to govern artificial intelligence. The EU AI Act categorizes technologies by risk – low, medium, high, and "unacceptable." Those deemed the most dangerous can, in Europe, be shut down entirely. It was a huge change in the tech world, but many may wonder why i…

1
S8 Episode 3 - In Vienna with Ian Palmer of Inchdairnie Distillery and Roland Grain of Ardgowan Distillery with whisky chat from the 2 Gordons 52:54

4M ago52:54

52:54

The 2 Gordons welcome Ian Palmer of Inchdairnie, referenced in the last podcast. Ian talks about the wording on Scotch whisky labels and talks about his own journey in establishing this wonderful Fife distillery. Roland Grain is the man behind Ardgowan distillery in Inverkip who also hosted the Potstill Masterclass Festival in Vienna where Gordon D…

1
Pregnancy in Urea Cycle Disorders 17:08

5M ago17:08

17:08

This episode brings together two popular podcast topics, pregnancy and urea cycle disorders. Dr Margreet Wagenmakers and Dr Karolina Stepien share recent insights from a literature review and international survey exploring the experiences of mothers with urea cycle disorders. The management and clinical outcomes of pregnancies in women with urea cy…

1
Pt.2 Chris Douvos of Ahoy Capital on the evolution of the emerging managers segment 18:23

5M ago18:23

18:23

Part 2 of our conversation with Chris Douvos, on how the Emerging Managers segment in Venture Capital has evolved since 2010. Chris Douvos founded Ahoy Capital in 2018, focusing on backing emerging venture capital fund managers. With nearly two decades in venture capital, he's a pioneer in the micro-VC movement. At Ahoy Capital, the focus is on int…

1
Shortcast: Clinical experience with glycerol phenylbutyrate in 20 patients with UCDs 9:15

5M ago9:15

9:15

Mel McSweeney and Dr Mildrid Yeo briefly outline the approach to urea cycle disorder management and the Gt Ormond Street experience using glycerol phenylbutyrate as a nitrogen scavenger. Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centreMildrid Yeo, et alhttps://doi.org/10.1002/jmd2.1…

1
How AI is taking the Biotech industry by storm 16:09

5M ago16:09

16:09

Mike & Amit talk about the future of Biotech, and how Artificial Intelligence may speed up healthcare and drug development. ********* Michael Wade is a Professor of Innovation and Strategy and Director of the IMD Global Center for Digital Business Transformation. He also holds the Cisco Chair in Digital Business Transformation. An expert in digital…

1
Liver directed gene therapy 33:50

5M ago33:50

33:50

The podcast returns to the subject of gene therapy, with Julien Baruteau, Nicola Brunetti-Pierri, and Paul Gissen discussing the potential of liver directed therapies with an emphasis on Wilson disease, Crigler-Najjar syndrome and PKU.Liver-directed gene therapy for inherited metabolic diseasesJulien Baruteau, Nicola Brunetti-Pierri, Paul Gissenhtt…

1
TV Narendran, CEO & Managing Director of Tata Steel 42:39

5M ago42:39

42:39

Anticipating rising raw material costs, Tata Steel’s CEO & Managing Director TV Narendran tells IMD President Jean-François Manzoni how he introduced a change management process to instill a culture of future readiness at the 100-year-old industrial company.By IMD

1
The Interview: Chris Tung, President of Strategic Development at Alibaba Group 34:24

5M ago34:24

34:24

Chris Tung is President of Strategic Development at Alibaba Group, a Chinese multinational specializing in e-commerce, retail, and technology. He tells IMD's Amit Joshi how the company is integrating AI to optimize... -- Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.By IMD

1
Henrik Andersen, CEO of sustainable energy leader Vestas 54:16

5M ago54:16

54:16

Henrik Andersen discusses with IMD President Jean-François Manzoni the challenges of navigating supply chain disruptions and soaring raw material costs over the past three years, and why he changed the wind farm developer’s culture to encourage openness and trust.By IMD

Podcasts Worth a Listen

IMD Podcasts

Podcasts Worth a Listen

Quick Reference Guide